Ignite Creation Date:
2024-05-05 @ 9:08 PM
Last Modification Date:
2024-10-26 @ 10:00 AM
Study NCT ID:
NCT00823914
Status:
COMPLETED
Last Update Posted:
2017-03-24
First Post:
2009-01-14
Brief Title:
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Study Overview
Official Title:
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective of the study is to create and validate Chronic Quality of Life CQOL index that explores habits career paths and other life choices psoriasis patients make as a result of coping with their disease that may not be impacted by therapy implemented at a given point in time
- The investigators think this data will show that patients who were diagnosed at a young age will have worse chronic quality of life
- The investigators think this data will show that patients who were diagnosed at a young age will have worse chronic quality of life
Detailed Description:
As a visible disease psoriasis can be embarrassing and psychosocially stressful in addition to physically uncomfortable Patients lives are affected in physical psychological social sexual and occupational aspects These burdens may cause patients to assume maladaptive habits and coping mechanisms leading to a downward spiral in functioning within society prohibiting patients from achieving their highest potential quality of life
The investigators study goal is to create and validate Chronic Quality of Life CQOL index that explores habits career paths and other life choices psoriasis patients make as a result of coping with their disease that may not be impacted by therapy implemented at a given point in time In creating this questionnaire and validating it the investigators will collect preliminary data The investigators think this data will show that patients who were diagnosed at a young age will have worse chronic quality of life In the long run the investigators will use the CQOL index in studies in which patients are treated for psoriasis to determine which treatments can change a psoriasis patients chronic quality of life This information will be used to create guidelines for treatment focused on achieving a patients optimal quality of life
Another aspect that the investigators would like to look at is the skin carotenoid levels in the psoriasis population Previous studies showed that psoriasis patients had lower levels of skin carotenoids when compared to healthy volunteers This observation was not statistically significant perhaps due to a small sample size 21 subjects in the psoriasis group and 35 subjects in the control group Skin carotenoid levels measurement is optional for study subjects
The investigators study goal is to create and validate Chronic Quality of Life CQOL index that explores habits career paths and other life choices psoriasis patients make as a result of coping with their disease that may not be impacted by therapy implemented at a given point in time In creating this questionnaire and validating it the investigators will collect preliminary data The investigators think this data will show that patients who were diagnosed at a young age will have worse chronic quality of life In the long run the investigators will use the CQOL index in studies in which patients are treated for psoriasis to determine which treatments can change a psoriasis patients chronic quality of life This information will be used to create guidelines for treatment focused on achieving a patients optimal quality of life
Another aspect that the investigators would like to look at is the skin carotenoid levels in the psoriasis population Previous studies showed that psoriasis patients had lower levels of skin carotenoids when compared to healthy volunteers This observation was not statistically significant perhaps due to a small sample size 21 subjects in the psoriasis group and 35 subjects in the control group Skin carotenoid levels measurement is optional for study subjects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None